CDKL4 Polyclonal Antibody

Dodavatel: Reddot Biotech USA Inc.
Teplota skladování: Store at -20°C. Avoid freeze / thaw cycles.
Katalogové číslo:
RD217783A/20
20μL
2 821,00 Kč
NA OBJEDNÁNÍ
RD217783A/60
60μL
5 526,00 Kč
NA OBJEDNÁNÍ
RD217783A/120
120μL
9 274,00 Kč
NA OBJEDNÁNÍ
RD217783A/200
200μL
15 417,00 Kč
NA OBJEDNÁNÍ
Velikost balení:
Cena bez DPH:
Dostupnost:
Vložit do košíku
Zobrazovat ceny: bez DPH / včetně DPH
This is a CDKL4 Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.
Cell cycle progression is controlled in part by a family of cyclin proteins and cyclin dependent kinases (Cdks). Cdk proteins work in concert with the cyclins to phosphorylate key substrates involved in each phase of cell cycle progression. Another family of proteins, Cdk inhibitors, also plays a role in regulating the cell cycle by binding to cyclin-Cdk complexes and modulating their activity. Cdks are considered potential targets for anti-cancer therapy due to their involvement with cell cycle regulation. Cdks are also involved in the regulation of transcription and mRNA processing. CdkL4 (cyclin-dependent kinase-like 4) is a 315 amino acid protein that belongs to the CMGC Ser/Thr protein kinase family and may be involved in cell cycle regulation.
ClonalityPolyclonal
Purification MethodAntigen affinity purification
IsotypeIgG
HostRabbit
ImmunogenSynthetic peptide of human CDKL4
SwissprotQ5MAI5
Calculated MW43 kDa
Observed MWRefer to figures
Gene AccessionNP001009565
ReactivityHuman,Mouse
ApplicationsWB,IHC,ELISA
ConjugationUnconjugated
DilutionWB 1:500-1:2000, IHC 1:30-1:150, ELISA 1:5000-1:10000
Concentration0.8 mg/mL
BufferPBS with 0.05% NaN3 and 40% Glycerol, pH7.4
0
RD217783A/120